The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, replaces a previous settlement deal that was rejected last year by the U.S. Supreme Court.
A new study from Australia involving over 83,000 participants found that prolonged standing may not improve heart health and could even increase the risk of certain circulatory problems.
Filed in the U.S. District Court for the Northern District of Illinois, the complaint says the drugstore chain’s pharmacists filled controlled substance prescriptions with clear red flags that indicated they were highly likely to be unlawful.